A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)

Autor: Awada, A. *, Bondarenko, I.N., Bonneterre, J., Nowara, E., Ferrero, J.M., Bakshi, A.V., Wilke, C., Piccart, M.
Zdroj: In Annals of Oncology April 2014 25(4):824-831
Databáze: ScienceDirect